[go: up one dir, main page]

WO2008104880A3 - Stable solid dosage forms of an antidepressant - Google Patents

Stable solid dosage forms of an antidepressant Download PDF

Info

Publication number
WO2008104880A3
WO2008104880A3 PCT/IB2008/000600 IB2008000600W WO2008104880A3 WO 2008104880 A3 WO2008104880 A3 WO 2008104880A3 IB 2008000600 W IB2008000600 W IB 2008000600W WO 2008104880 A3 WO2008104880 A3 WO 2008104880A3
Authority
WO
WIPO (PCT)
Prior art keywords
solid dosage
stable solid
antidepressant
dosage forms
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2008/000600
Other languages
French (fr)
Other versions
WO2008104880A2 (en
Inventor
Krishna Murthy Bhavanasi
Venkata Ram Mohan Rao Visinigiri
Manoj Kanti Saha
Nagaprasad Vishnubhotla
Sivakumaran Meenakshisunderam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aurobindo Pharma Ltd
Original Assignee
Aurobindo Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurobindo Pharma Ltd filed Critical Aurobindo Pharma Ltd
Priority to EP08709891A priority Critical patent/EP2134325A2/en
Publication of WO2008104880A2 publication Critical patent/WO2008104880A2/en
Publication of WO2008104880A3 publication Critical patent/WO2008104880A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a stable solid dosage form comprising an anti-depressant. More particularly, the present invention relates to stable solid dosage form of escitalopram or its salts. The present invention also relates to a process for the preparation of stable solid dosage form of escitalopram or its salts.
PCT/IB2008/000600 2007-03-01 2008-02-28 Stable solid dosage forms of an antidepressant Ceased WO2008104880A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08709891A EP2134325A2 (en) 2007-03-01 2008-02-28 Stable solid dosage forms of an antidepressant

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN424CH2007 2007-03-01
IN424/CHE/2007 2007-03-01

Publications (2)

Publication Number Publication Date
WO2008104880A2 WO2008104880A2 (en) 2008-09-04
WO2008104880A3 true WO2008104880A3 (en) 2008-11-20

Family

ID=39721657

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2008/000600 Ceased WO2008104880A2 (en) 2007-03-01 2008-02-28 Stable solid dosage forms of an antidepressant

Country Status (2)

Country Link
EP (1) EP2134325A2 (en)
WO (1) WO2008104880A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104523638B (en) * 2014-11-28 2020-02-21 浙江华海药业股份有限公司 Tablet containing escitalopram oxalate and preparation method thereof
CN106176691A (en) * 2016-08-31 2016-12-07 齐鲁制药有限公司 A kind of molten membrane of escitalopram oxalate mouth and preparation method thereof
CN106860410A (en) * 2017-03-17 2017-06-20 万全万特制药江苏有限公司 A kind of escitalopram oxalate oral disintegrating tablet and preparation method thereof
WO2018190294A1 (en) * 2017-04-10 2018-10-18 東和薬品株式会社 Medicinal composition comprising escitalopram
KR102089737B1 (en) 2017-11-01 2020-03-16 한국화학연구원 A sustained-release injection of microspheres containing escitalopram and manufacturing method thereof
JP2023018887A (en) * 2021-07-28 2023-02-09 共和薬品工業株式会社 Escitalopram oxalate-containing tablet

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943590A (en) * 1988-06-14 1990-07-24 H. Lundbeck A/S Pharmaceutically useful (+)-1-(3-dimethylaminopropyl)-1-(4'-fluorophenyl)-1,3-dihydrosobenzofuran-5-carbonitrile and non-toxic acid addition salts thereof
US20050250838A1 (en) * 2004-05-04 2005-11-10 Challapalli Prasad V Formulation for sustained delivery
WO2006123243A2 (en) * 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
WO2006136169A2 (en) * 2005-06-22 2006-12-28 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943590A (en) * 1988-06-14 1990-07-24 H. Lundbeck A/S Pharmaceutically useful (+)-1-(3-dimethylaminopropyl)-1-(4'-fluorophenyl)-1,3-dihydrosobenzofuran-5-carbonitrile and non-toxic acid addition salts thereof
US20050250838A1 (en) * 2004-05-04 2005-11-10 Challapalli Prasad V Formulation for sustained delivery
WO2006123243A2 (en) * 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
WO2006136169A2 (en) * 2005-06-22 2006-12-28 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base

Also Published As

Publication number Publication date
WO2008104880A2 (en) 2008-09-04
EP2134325A2 (en) 2009-12-23

Similar Documents

Publication Publication Date Title
WO2010049454A3 (en) Antimicrobial composition from copepods
WO2007093627A3 (en) Biocidal composition
WO2010015657A3 (en) Alkoxypyrazoles and the process for their preparation
WO2006065480A3 (en) Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control
WO2007133802A3 (en) Pharmaceutical formulations of pimavanserin
WO2007098270A3 (en) Co-crystals comprising vx-950 and pharmaceutical compositions comprising the same
WO2010114275A3 (en) Composition for inhibiting erythema caused by ultraviolet radiation containing a dipeptide as active ingredient
WO2007127292A3 (en) Tigeycline crystalline forms and processes for preparation thereof
WO2011157722A3 (en) Solid ivabradine-containing composition
WO2009004593A3 (en) Processes for the preparation of epinephrine
WO2006074951A3 (en) Orally disintegrating composition of olanzapine or donepezil
WO2007132354A3 (en) Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof
WO2008104880A3 (en) Stable solid dosage forms of an antidepressant
WO2009053446A3 (en) Pregabalin intermediates and process for preparing them and pregabalin
WO2010049449A3 (en) Novel salts of sunitinib
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2010004575A3 (en) Preparation of escitalopram, its salts and intermediates
WO2008137134A3 (en) Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
WO2010079045A3 (en) Crystalline salt forms of flibanserine
WO2010015656A3 (en) Alkoxypyrazoles and the process for their preparation
WO2009065872A3 (en) Processes for the synthesis of varenicline l-tartrate
WO2010117979A3 (en) Serotonin and norepinephrine reuptake inhibitor
WO2010039885A3 (en) Crystalline forms of dexlansoprazole
UA43461U (en) METHOD OF OBTAINING ESCITALOPROM
WO2009122429A3 (en) Crystalline oxybutynin and process for preparing the same

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 5680/CHENP/2008

Country of ref document: IN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08709891

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008709891

Country of ref document: EP